IAB56 RPT agent is designed to target integrin αvβ6, a receptor over-expressed in a broad range of solid cancers underserved by current cancer therapies. IAB57 RPT agent is designed to target DLL3, a target over-expressed in cancer tissues and relevant in several cancers, most notably Small-Cell Lung Cancer (SCLC) LOS ANGELES, May 18, 2023 /PRNewswire/ … Read more
PROVIDENCE, R.I., 18. Mai 2023 /PRNewswire/ — EpiVax, Inc. (“EpiVax”) feiert seinen 25sten Geburtstag, indem das Unternehmen sein Engagement für die Verbesserung der menschlichen Gesundheit überall auf der Welt erneuert und gleichzeitig die Entwicklung bahnbrechender Instrumente durch das Unternehmen hervorhebt. Darüber hinaus würdigt EpiVax die Arbeit von zwei gemeinnützigen Organisationen, die in diesen 25 Jahren … Read more
Recommendation will enable eligible patients in England, Wales and Northern Ireland to access the first licensed treatment for moderate-to-severe chronic kidney disease (CKD)-associated pruritus in adult patients on haemodialysis ST. GALLEN, Switzerland and STAMFORD, Conn., May 18, 2023 /PRNewswire/ — Vifor Fresenius Medical Care Renal Pharma (VFMCRP) and Cara Therapeutics, Inc. (Nasdaq: CARA) today announced that … Read more
Recommendation will enable eligible patients in England, Wales and Northern Ireland to access the first licensed treatment for moderate-to-severe chronic kidney disease (CKD)-associated pruritus in adult patients on haemodialysis ST. GALLEN, Switzerland and STAMFORD, Conn., May 18, 2023 /PRNewswire/ — Vifor Fresenius Medical Care Renal Pharma (VFMCRP) and Cara Therapeutics, Inc. (Nasdaq: CARA) today announced that … Read more
Gleneagles is among the few hospitals in Malaysia that continually invests in clinical data solutions to improve patient outcomes using procedural clinical data. SAN ANTONIO, May 17, 2023 /PRNewswire/ — Frost & Sullivan recently assessed the healthcare industry and, based on its findings, recognizes Gleneagles Hospital Kuala Lumpur with the 2023 Malaysia Hospital Customer Value Leadership Award. … Read more
DUBLIN, May 17, 2023 /PRNewswire/ — The “Global Non-Invasive Cancer Diagnostics Market Size, Trends and Growth Opportunity, By Type, By Product Type, By Test Type, By Application, By End Users, By Region and forecast till 2030” report has been added to ResearchAndMarkets.com’s offering. The global non-invasive cancer diagnostics market was valued at USD 145 billion by … Read more
Company sets refreshed global strategy and new US initiatives for Oxiplex® portfolio of adhesion barrier products in women’s health, spine, orthopedics and general surgery. SAN LUIS OBISPO, Calif., May 17, 2023 /PRNewswire/ — FzioMed, Inc. (“FzioMed” or the “Company”), a global leading surgical biomaterials company focused on spine, orthopedic, peritoneal and gynecological surgery, today announced … Read more
Patent Trial and Appeal Board Invalidates Agilent U.S. Patents 10,337,001 and 10,900,034 REDWOOD CITY, Calif., May 17, 2023 /PRNewswire/ — Synthego Corp., a leading provider of genome engineering solutions, has announced a victory in its dispute with Agilent Technologies, Inc., regarding two of Agilent’s patents which have been invalidated today by a ruling of the … Read more
PALM BEACH GARDENS, Fla., May 17, 2023 /PRNewswire/ — Nicklaus Companies and ahead – provider of premium golf and leisure headwear – today announced that they have partnered with American Skin Association (ASA) to raise awareness about melanoma and educate golfers on the importance of sun safety. May is Melanoma Awareness Month and Nicklaus Companies and … Read more
NEW YORK, May 17, 2023 /PRNewswire/ — The over-the-counter drug market size is set to grow by USD 58.54 billion from 2022 to 2027. The market is expected to register progress at a CAGR of 6.53%, according to Technavio’s latest market research report estimates. With a focus on identifying dominant industry influencers, Technavio’s reports present a detailed study by … Read more